Sponsor:
Beth Israel Deaconess Medical Center
Code:
NCT04693533
Conditions
Migraine Disorders
Sleep Disorder
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Fremanezumab Prefilled Syringe [Ajovy]
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-16. This information was provided to ClinicalTrials.gov by Beth Israel Deaconess Medical Center on 2025-01-22.